AI assistant
Sending…
REGENXBIO Inc. — Director's Dealing 2017
May 26, 2017
32827_dirs_2017-05-26_0cc5332d-438a-4e0e-b56b-d09708c6f560.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2017-05-24
Reporting Person: BESHAR LUKE M (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-24 | Stock Option (Right to Buy) | $18.85 | A | 12500 | Acquired | 2027-05-24 | Common Stock (12500) | Direct |
Footnotes
F1: The option will vest in 12 equal monthly installments following May 24, 2017.
More from REGENXBIO Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Feb 10
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Jan 29
Regulatory Filings
2026
Jan 28
Major Shareholding Notification
2026
Jan 21